This Week in Nephrology — Sep 23, 2026

Editor's Pick: Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act (JAMA, 2026)

Welcome to This Week in Nephrology. This week we're covering 10 notable papers spanning kidney transplantation — from insurance-driven access barriers to intentional immune tolerance — glomerular disease diagnostics and immunosuppression, and a clust…

This week's papers: 1. Medicare Advantage Enrollment and Access to Kidney Transplant After the 21st Century Cures Act. — JAMA 2026 2. Evaluation of eculizumab for the prevention of delayed graft function after kidney transplantation in adults: A randomized, double-blind, placebo-controlled tr… — American Journal of Transplantation 2026 3. Delayed immune tolerance intentionally achieved years after two-haplotype matched kidney transplantation. — American Journal of Transplantation 2026 4. Automated chemiluminescence immunoassay for the detection of anti-nephrin autoantibodies. — Kidney International 2026 5. Rituximab With or Without Avacopan in ANCA-Associated Vasculitis With Severe Renal Involvement. — Kidney International Reports 2026 6. Approach to Hematuria: Core Curriculum 2026. — American Journal of Kidney Diseases 2026 7. Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD. — American Journal of Kidney Diseases 2026 8. Normoproteic Plant-Dominant Protein Diets, Uremic Toxins, and Gut Microbiota in Patients With Advanced CKD: A Randomized Controlled Trial. — American Journal of Kidney Diseases 2026 9. Hypertensive Disorders of Pregnancy and Cardiovascular-Kidney-Metabolic Syndrome. — Hypertension 2026 10. Self-Reported Versus Performance-Based Measures of Physical Function and Mortality Among Patients With Kidney Failure: A Cohort Analysis of the CONVINCE Trial. — American Journal of Kidney Diseases 2026

Listen at https://audioscholar.cc/episode/v9neqk96wx